Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 12, 2012 - Issue 4
Submit an article Journal homepage
575
Views
15
CrossRef citations to date
0
Altmetric
Drug Evaluations

Eculizumab for treatment of asthma

Steven G SmithMcMaster University, Department of Medicine, HSC 3U26, 1200 Main St West, Hamilton, Ontario L8N 3Z5, Canada+905 521 2100 ext 22791; +905 528 1807; [email protected]
, MSc,
Brittany WatsonMcMaster University, Department of Medicine, HSC 3U26, 1200 Main St West, Hamilton, Ontario L8N 3Z5, Canada+905 521 2100 ext 22791; +905 528 1807; [email protected]
, BSc,
Gordon ClarkMcMaster University, Department of Medicine, HSC 3U26, 1200 Main St West, Hamilton, Ontario L8N 3Z5, Canada+905 521 2100 ext 22791; +905 528 1807; [email protected]
, BSc &
Gail M GauvreauMcMaster University, Department of Medicine, HSC 3U26, 1200 Main St West, Hamilton, Ontario L8N 3Z5, Canada+905 521 2100 ext 22791; +905 528 1807; [email protected]
, PhD
Pages 529-537 | Published online: 13 Mar 2012

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christopher L. Grainge, Steven Maltby, Peter G. Gibson, Peter A. B. Wark & Vanessa M. McDonald. (2016) Targeted therapeutics for severe refractory asthma: monoclonal antibodies. Expert Review of Clinical Pharmacology 9:7, pages 927-941.
Read now

Articles from other publishers (14)

Esther Benamu. (2020) Infectious Risks Associated with Biologics Targeting Janus Kinase-Signal Transducer and Activator of Transcription Signaling and Complement Pathway for Inflammatory Diseases. Infectious Disease Clinics of North America 34:2, pages 271-310.
Crossref
N.O. Pereverzina, L.S. Kruglova & I.E. Musaev. (2020) Present and future in the treatment of chronic spontaneous urticaria. Klinicheskaya dermatologiya i venerologiya 19:5, pages 604.
Crossref
K.L. Winthrop, X. Mariette, J.T. Silva, E. Benamu, L.H. Calabrese, A. Dumusc, J.S. Smolen, J.M. Aguado & M. Fernández-Ruiz. (2018) ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). Clinical Microbiology and Infection 24, pages S21-S40.
Crossref
Emek Kocatürk, Marcus Maurer, Martin Metz & Clive Grattan. (2017) Looking forward to new targeted treatments for chronic spontaneous urticaria. Clinical and Translational Allergy 7:1.
Crossref
Esther Benamu & José G. Montoya. (2016) Infections associated with the use of eculizumab. Current Opinion in Infectious Diseases 29:4, pages 319-329.
Crossref
Rahul Suresh, Prabha Chandrasekaran, Fayyaz S. Sutterwala & David M. Mosser. (2016) Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation. Journal of Cell Science 129:9, pages 1928-1939.
Crossref
M. Cataldi. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Patrick D. Mitchell, Amani I. El-Gammal & Paul M. O’Byrne. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 131 152 .
PD Mitchell, AI El-Gammal & PM O'Byrne. (2016) Emerging monoclonal antibodies as targeted innovative therapeutic approaches to asthma. Clinical Pharmacology & Therapeutics 99:1, pages 38-48.
Crossref
Francesco Menzella, Mirco Lusuardi, Carla Galeone & Luigi Zucchi. (2015) Tailored therapy for severe asthma. Multidisciplinary Respiratory Medicine 10:1.
Crossref
Pieter S. Hiemstra. (2015) Parallel activities and interactions between antimicrobial peptides and complement in host defense at the airway epithelial surface. Molecular Immunology 68:1, pages 28-30.
Crossref
Karen H. Calhoun. (2015) Asthma treatments: new and emerging therapies. International Forum of Allergy & Rhinology 5:S1, pages S76-S81.
Crossref
Elizabeth B. Staab, Sam D. Sanderson, Sandra M. Wells & Jill A. Poole. (2014) Treatment with the C5a receptor/CD88 antagonist PMX205 reduces inflammation in a murine model of allergic asthma. International Immunopharmacology 21:2, pages 293-300.
Crossref
Inken Schmudde, Yves Laumonnier & Jörg Köhl. (2013) Anaphylatoxins coordinate innate and adaptive immune responses in allergic asthma. Seminars in Immunology 25:1, pages 2-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.